CSI Market
Sign In | Register

Iradimed (IRMD) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access IRMD quarterly Cash Flow →
The table below presents a historical view of Iradimed's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income22.48
Depreciation & amortization1.17
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Impairment of Intangible Assets, Finite-lived0.00
Provision For Loan Losses Expensed-0.08
Inventories Decrease /-Increase-1.33
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.04
Share-based Compensation2.92
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Write Off Of Non Trade Accounts Receivable-
Increase Decrease In Warranty Reserve0.03
Increase Decrease In Contract With Customer Liability-
Income taxes1.96
Realized Investment Gains (Losses), Total0.00
Accounts Receivable-3.58
Increase (Decrease) in Accounts Payable-0.08
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.02
Other Working Capital-0.19
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.60
Discontinued operations0.00
Net Cash flow from Operating Activities24.95
Investing Activities
Capital Expenditures-8.42
Sale of Capital Items0.00
Payments for (Proceeds from) Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale, Maturity and Collection of Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-8.42
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-54.80
Income Tax Benefits Credited To Equity-
Proceeds From Issuance Of Stock Option And Warrants Exercised-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents52.23
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-15.04
Net Cash Flow from Financing Activities-17.60
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow16.53
Total Cash Flow-1.08
4 historic quarters locked

Sign in to unlock the full Iradimed cash flow history.

Sign In Create Free Account

About Iradimed Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-024691

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License